Quality Assurance, Quality Control & Biosimilars Manufacturing – Walk-In – 1st June

Lupin Limited is a prominent Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. Established in 1968 by Dr. Desh Bandhu Gupta, the company began with a modest ₹5,000 loan and has since evolved into a global healthcare leader . 🏢 Company Overview Founder: Dr. Desh Bandhu Gupta CEO: Vinita D. Gupta Managing Director: Nilesh Gupta Headquarters: Mumbai, India Employees: Over 22,000 Global Presence: Products distributed in over 100 countries Manufacturing Sites: 15 Research Centers: 7 💊 Business Segments Lupin's operations encompass a wide range of pharmaceutical products and services: Generic Drugs: Lupin is a leading supplier of generic medicines, particularly in oral solids, injectables, and topicals . Branded Formulations: In India, Lupin is a dominant player in branded formulations, with strong presence in cardiovascular, diabetes, gastrointestinal, and anti-infectives . Biosimilars and Specialty Drugs: Lupin has invested heavily in biosimilars and complex specialty products, targeting areas like respiratory therapies, ophthalmology, and women’s health . Active Pharmaceutical Ingredients (APIs): Lupin manufactures APIs for internal use and exports, maintaining high quality and compliance standards . Startnet India Diagnostics: Lupin forayed into the diagnostics business in December 2021 to provide a comprehensive range of diagnostic tests in India, including molecular diagnostics, cytogenetics, flow cytometry, microbiology, and serology . Wikipedia 🌍 Global Presence Lupin has a significant presence in several key markets: United States: The U.S. is Lupin’s largest market, contributing around 40-45% of revenues. The company focuses on generics, biosimilars, and specialty medicines in this market . India: India is a stronghold for branded formulations and over-the-counter medicines. Lupin ranks among the top 5 pharma companies domestically . Startnet India Japan and Europe: Lupin is one of the top generic players in Japan and continues to expand in regulated European markets . Startnet India Emerging Markets: Lupin is making strategic moves in Latin America, Southeast Asia, and Africa, aiming to provide affordable healthcare solutions in underserved regions . Startnet India 🔬 Research & Development Lupin places a strong emphasis on research and development, with annual investments ranging from 9% to 11% of revenue. The company operates 6 global R&D centers and 11 manufacturing sites, focusing on complex generics, biosimilars, and novel drug delivery systems . 🌱 Corporate Social Responsibility Lupin is committed to enriching communities through its CSR arm, the Lupin Human Welfare and Research Foundation. The foundation has positively impacted the lives of over 1.57 million people across 4,771 villages in eight states of India .